Abstract

Objective: Inflammatory cytokines are increased during one-lung ventilation in patients undergoing lung resection, and this increase can be fatal. Propofol and sevoflurane are the main anesthetics used for these patients. Unfortunately, there is no consensus on the best choice of an anesthetic agent concerning an inflammatory response in patients undergoing lung resection. This meta-analysis aimed to compare the effects of propofol and sevoflurane on the inflammatory response in patients undergoing lung resection.Methods: We searched electronic databases to identify randomized controlled trials comparing the effects of different anesthetics (sevoflurane vs. propofol) on the inflammatory response. The primary outcome concerned the concentration of systemic inflammatory cytokines. The secondary outcomes concerned the concentrations of inflammatory cytokines in the bronchoalveolar lavage (BAL) fluid from the dependent and independent lung. Random effects analysis of the meta-analyses were performed to synthesize the evidence and to assess the concentrations of inflammatory factors in the sevoflurane and propofol groups.Results: Eight trials involving 488 participants undergoing lung resection with one-lung ventilation were included. There was no significant difference in the concentrations of systemic interleukin (IL)-6, IL-10, or tumor necrosis factor α between the sevoflurane and propofol groups. Compared with the propofol group, BAL levels of IL-6 in the dependent ventilated lung were decreased in the sevoflurane group (three trials, 256 participants; standardized mean difference [SMD], −0.51; 95% confidence interval [CI], −0.90 to −0.11; p = 0.01; I2 = 46%). The BAL levels of IL-6 in the independent ventilated lung were also decreased by sevoflurane (four trials, 362 participants; SMD, −0.70; 95% [CI], −0.93 to −0.47; p < 0.00001; I2 = 0%).Conclusions: There was no difference in the systemic inflammatory response between the sevoflurane and propofol groups. However, compared with propofol, sevoflurane can reduce the local alveolar inflammatory response. Additional research is necessary to confirm whether the inflammatory response is direct or indirect.

Highlights

  • The incidence of lung cancer is currently increasing and lung resection is believed to be an important treatment for this malignancy [1]

  • The results from a human study suggested that intraoperative inflammatory cytokines were increased in patients undergoing thoracic surgery [5], and temporary lung collapse and surgical operations could enhance the expression of inflammatory mediators [3, 6, 7]

  • The results of this study showed no difference in systemic inflammatory factors (IL-6, IL-10, tumor necrosis factor α (TNF-α)) between the two groups

Read more

Summary

Introduction

The incidence of lung cancer is currently increasing and lung resection is believed to be an important treatment for this malignancy [1]. The initial response is the release of TNF-α by activated macrophages and monocytes in damaged tissue. This stimulates the production and release of more cytokines, IL-6, which is the main cytokine in the acute phase response and is responsible for inducing systemic changes [4]. Animal experiments showed that reexpansion of the lung after a short period of OLV caused the release of alveolar pro-inflammatory cytokines [5]. The results from a human study suggested that intraoperative inflammatory cytokines were increased in patients undergoing thoracic surgery [5], and temporary lung collapse and surgical operations could enhance the expression of inflammatory mediators [3, 6, 7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call